Titre:
  • Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Auteur:Goss, Paul E; Ingle, James N; Martino, S; Robert, Nicholas J; Muss, Hyman B; Piccart-Gebhart, Martine; Castiglione, Monica; Tu, Dongsheng; Shepherd, L; Pritchard, Kathleen; Livingston, Robert; Davidson, Nancy E; Norton, Larry; Perez, Edith A; Abrams, Jeffrey S; Cameron, David A; Palmer, Michael J; Pater, Joseph L; National Cancer Institute of Canada Clinical Trials Group MA.17,
Informations sur la publication:Journal of clinical oncology, 25, 15, page (2006-2011)
Statut de publication:Publié, 2007-05
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- pathology
Canada -- epidemiology
Chemotherapy, Adjuvant
Disease-Free Survival
Double-Blind Method
Female
Humans
Middle Aged
Nitriles -- administration & dosage
Placebos
Postmenopause
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Retrospective Studies
Survival Rate
Tamoxifen -- administration & dosage
Treatment Outcome
Triazoles -- administration & dosage
Note générale:Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2006.09.4482
info:pii/JCO.2006.09.4482
info:pmid/17452676